UPDATED May 24, 2024
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
AZN | UK£122.96 | 1.5% | 4.3% | UK£190.6b | UK£133.52 | PE38.4x | E14.6% | 2.0% | ||
GSK | UK£17.75 | -0.03% | 27.5% | UK£72.4b | UK£20.32 | PE16.1x | E12.2% | 3.3% |